Cantitate/Preț
Produs
Total produse
Vezi coșul
Applied Surrogate Endpoint Evaluation Methods with SAS and R de Ariel Alonso

Applied Surrogate Endpoint Evaluation Methods with SAS and R: Chapman & Hall/CRC Biostatistics Series

Autor Ariel Alonso, Theophile Bigirumurame, Tomasz Burzykowski, Marc Buyse, Geert Molenberghs, Leacky Muchene, Nolen Joy Perualila, Ziv Shkedy, Wim Van der Elst
en Limba Engleză Paperback – 18 dec 2020
An important factor that affects the duration, complexity and cost of a clinical trial is the endpoint used to study the treatment’s efficacy. When a true endpoint is difficult to use because of such factors as long follow-up times or prohibitive cost, it is sometimes possible to use a surrogate endpoint that can be measured in a more convenient or cost-effective way. This book focuses on the use of surrogate endpoint evaluation methods in practice, using SAS and R.
Citește tot Restrânge

Din seria Chapman & Hall/CRC Biostatistics Series

  • Medical Risk Prediction Models: With Ties to Machine Learning
    Preț: 38662 lei
  • 5% Hybrid Frequentist/Bayesian Power and Bayesian Power in Planning Clinical Trials
    Preț: 33817 lei
  • 5% Biostatistics for Bioassay
    Preț: 65694 lei
  • Joint Models for Longitudinal and Time-to-Event Data: With Applications in R
    Preț: 34142 lei
  • Real-World Evidence in a Patient-Centric Digital Era
    Preț: 35591 lei
  • Interface between Regulation and Statistics in Drug Development
    Preț: 35448 lei
  • Structural Equation Modeling for Health and Medicine
    Preț: 34289 lei
  • Cure Models: Methods, Applications, and Implementation
    Preț: 28880 lei
  • Sample Size Calculations in Clinical Research
    Preț: 31141 lei
  • 9% ROC Analysis for Classification and Prediction in Practice
    Preț: 64457 lei
  • 9% Quantitative Methods for Precision Medicine: Pharmacogenomics in Action
    Preț: 60832 lei
  • Signal Detection for Medical Scientists: Likelihood Ratio Test-based Methodology
    Preț: 35663 lei
  • Real-World Evidence in Drug Development and Evaluation
    Preț: 35477 lei
  • 8% Statistical Thinking in Clinical Trials
    Preț: 37664 lei
  • Single-Arm Phase II Survival Trial Design
    Preț: 37230 lei
  • Bayesian Adaptive Methods for Clinical Trials
    Preț: 35065 lei
  • 9% Value of Information for Healthcare Decision-Making
    Preț: 76627 lei
  • Confidence Intervals for Discrete Data in Clinical Research
    Preț: 38163 lei
  • Applied Meta-Analysis with R and Stata
    Preț: 35663 lei
  • 9% Bayesian Precision Medicine
    Preț: 68419 lei
  • 9% Statistical Design, Monitoring, and Analysis of Clinical Trials: Principles and Methods
    Preț: 59430 lei
  • Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies
    Preț: 31141 lei
  • 9% Statistical Methods for Dynamic Disease Screening and Spatio-Temporal Disease Surveillance
    Preț: 68446 lei
  • 9% Innovative Methods for Rare Disease Drug Development
    Preț: 83328 lei
  • 9% Causal Inference in Pharmaceutical Statistics
    Preț: 68267 lei
  • Bayesian Methods in Pharmaceutical Research
    Preț: 36200 lei
  • 9% Analysis of Incidence Rates
    Preț: 94038 lei
  • 18% Design and Analysis of Clinical Trials for Predictive Medicine
    Preț: 79114 lei
  • 18% Bayesian Methods in Health Economics
    Preț: 70657 lei
  • 18% Medical Biostatistics
    Preț: 173031 lei
  • 26% Dose Finding by the Continual Reassessment Method
    Preț: 87513 lei
  • 18% Design and Analysis of Bridging Studies
    Preț: 78560 lei
  • 25% Statistics In the Pharmaceutical Industry
    Preț: 82563 lei
  • 15% Fundamental Concepts for New Clinical Trialists
    Preț: 67814 lei
  • 25% Statistical Methods for Drug Safety
    Preț: 55758 lei
  • 25% Randomization, Masking, and Allocation Concealment
    Preț: 62583 lei
  • 18% Quantitative Methods for HIV/AIDS Research
    Preț: 78638 lei
  • 25% Design and Analysis of Bioavailability and Bioequivalence Studies
    Preț: 77807 lei
  • 25% Exposure-Response Modeling: Methods and Practical Implementation
    Preț: 62829 lei
  • 18% Modern Adaptive Randomized Clinical Trials: Statistical and Practical Aspects
    Preț: 112497 lei
  • 25% Handbook of Regression and Modeling: Applications for the Clinical and Pharmaceutical Industries
    Preț: 88755 lei
  • 25% Randomized Phase II Cancer Clinical Trials
    Preț: 52681 lei
  • 25% Applied Biclustering Methods for Big and High-Dimensional Data Using R
    Preț: 56034 lei
  • 15% Adaptive Design Theory and Implementation Using SAS and R
    Preț: 47986 lei
  • 18% Monte Carlo Simulation for the Pharmaceutical Industry: Concepts, Algorithms, and Case Studies
    Preț: 101763 lei
  • 18% Patient-Reported Outcomes: Measurement, Implementation and Interpretation
    Preț: 111551 lei

Preț: 31414 lei

Preț vechi: 35749 lei
-12% Nou

Puncte Express: 471
Preț estimativ în valută:
6012€ • 6223$ • 5081£

Carte tipărită la comandă

Livrare economică 05-19 martie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780367736552
ISBN-10: 0367736551
Pagini: 396
Dimensiuni: 156 x 234 mm
Greutate: 0.54 kg
Ediția:1
Editura: CRC Press
Colecția Chapman and Hall/CRC
Seria Chapman & Hall/CRC Biostatistics Series

Public țintă

Professional Practice & Development

Cuprins

Introductory Material. Introduction. Notation and Example Datasets. The History of Surrogate Endpoint Validation. Contemporary Surrogate Endpoint Evaluation Methods. Multiple-Trial Surrogate Endpoint Evaluation Methods. Two Continuous Outcomes. Two Survival Endpoints. Two Categorical Endpoints. A Categorical and a Continuous Endpoint. A Survival and a Continuous Endpoint. A Survival and a Categorical Endpoint. Two Longitudinal Endpoints. A Longitudinal and a Survival Endpoint. Additional Considerations and Further Topics. Software Details. An Alternative Surrogate Endpoint Evaluation Framework: Causal-Inference. Surrogate Endpoint Evaluation Methods in Small Samples. Construction and Evaluation of Genetic Biomarkers in Early Drug Development Experiments. Additional Considerations.

Notă biografică

Ariel Alonso, Theophile Bigirumurame, Tomasz Burzykowski, Marc Buyse, Geert Molenberghs, Leacky Muchene, Nolen Joy Perualila, Ziv Shkedy, Wim Van der Elst

Recenzii

"This is a timely text. The number of published studies using surrogate endpoints has increased dramatically since the early work of the 1980s; however, there is a dearth of available texts or software on this topic. Anyone with an interest in surrogate endpoint evaluation would benefit from this text."
~Statistics in Medicine

Descriere

When a true endpoint is difficult to use because of such factors as long follow-up times or prohibitive cost, it is sometimes possible to use a surrogate endpoint that can be measured in a more convenient or cost-effective way. This book focuses on the use of surrogate endpoint evaluation methods in practice, using SAS and R.